- Home
- STNG vs CRNX Comparison
STNG vs CRNX Comparison
Compare STNG & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STNG
- CRNX
- Stock Information
- Founded
- STNG 2009
- CRNX 2008
- Country
- STNG Monaco
- CRNX United States
- Employees
- STNG N/A
- CRNX N/A
- Industry
- STNG Marine Transportation
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- STNG Consumer Discretionary
- CRNX Health Care
- Exchange
- STNG Nasdaq
- CRNX Nasdaq
- Market Cap
- STNG 3.1B
- CRNX 2.8B
- IPO Year
- STNG 2010
- CRNX 2018
- Fundamental
- Price
- STNG $60.61
- CRNX $40.17
- Analyst Decision
- STNG Strong Buy
- CRNX Buy
- Analyst Count
- STNG 5
- CRNX 12
- Target Price
- STNG $64.40
- CRNX $74.45
- AVG Volume (30 Days)
- STNG 806.8K
- CRNX 2.0M
- Earning Date
- STNG 10-30-2025
- CRNX 11-06-2025
- Dividend Yield
- STNG 2.65%
- CRNX N/A
- EPS Growth
- STNG N/A
- CRNX N/A
- EPS
- STNG 7.37
- CRNX N/A
- Revenue
- STNG $916,164,000.00
- CRNX $1,392,000.00
- Revenue This Year
- STNG N/A
- CRNX $428.87
- Revenue Next Year
- STNG $2.40
- CRNX $958.11
- P/E Ratio
- STNG $7.93
- CRNX N/A
- Revenue Growth
- STNG N/A
- CRNX 0.51
- 52 Week Low
- STNG $30.63
- CRNX $24.10
- 52 Week High
- STNG $62.90
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- STNG 65.26
- CRNX 48.59
- Support Level
- STNG $56.34
- CRNX $40.72
- Resistance Level
- STNG $58.99
- CRNX $43.09
- Average True Range (ATR)
- STNG 2.03
- CRNX 1.84
- MACD
- STNG 0.33
- CRNX -0.72
- Stochastic Oscillator
- STNG 94.00
- CRNX 4.70
About STNG Scorpio Tankers Inc.
Scorpio Tankers Inc is a provider of marine transportation of petroleum products. It owned, lease financed, or chartered in vessels spanning three different vessel segments Handymax, MR, and LR2. The company's fleet of tankers is the eco-friendly, and newest fleet on the water hauling clean petroleum products. It provides seaborne transportation of crude oil and refined petroleum products. The company generates the majority of its revenue from LR2.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.